Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PFDN1 pseudogene 2 (PFDN1P2) is a pseudogene related to prefoldin subunit 1, a member of the prefoldin family of molecular chaperones. Unlike its parent gene (PFDN1), which codes for a component of the hexameric prefoldin complex involved in protein folding, PFDN1P2 does not produce a functional protein product. There is currently no evidence of biological activity, protein-coding capability, or disease relevance for PFDN1P2. It is not considered a therapeutic target, receptor, enzyme, or biomarker, and is not associated with drug interactions, mechanisms of action, or safety concerns. The functional prefoldin complex is important for maintaining protein homeostasis, cytoskeletal assembly, and is implicated in various cancers[1][3][5]. However, none of these roles are attributed to the PFDN1 pseudogene 2. If you intended information about the functional protein PFDN1 or PFDN2, rather than the pseudogene, please clarify, as those are molecular chaperones with disease roles, molecular interactions, and possible targeting relevance[3][5].
There are no mechanisms of action relevant to PFDN1P2 from a pharmacological standpoint.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prefoldin subunit 1 pseudogene 2 (PFDN1P2).